Bayview Acquisition Corp Class A Ordinary Shares (BAYA) - Total Liabilities
Based on the latest financial reports, Bayview Acquisition Corp Class A Ordinary Shares (BAYA) has total liabilities worth $6.26 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bayview Acquisition Corp Class A Ordinary Shares - Total Liabilities Trend (2023–2025)
This chart illustrates how Bayview Acquisition Corp Class A Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. See Bayview Acquisition Corp Class A Ordinar current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Bayview Acquisition Corp Class A Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of Bayview Acquisition Corp Class A Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Optomed PLC
HE:OPTOMED
|
Finland | €6.95 Million |
|
S H L Telemedicine Ltd
SW:SHLTN
|
Switzerland | CHF40.82 Million |
|
Coreana Cosmetics Co.Ltd
KQ:027050
|
Korea | ₩16.69 Billion |
|
SK Discovery Co Ltd
KO:006125
|
Korea | ₩8.93 Trillion |
|
OnKure Therapeutics, Inc.
NASDAQ:OKUR
|
USA | $6.41 Million |
|
Laird Superfood Inc
NYSE MKT:LSF
|
USA | $7.76 Million |
|
Phaos Technology Holdings (Cayman) Limited
NYSE MKT:POAS
|
USA | $3.90 Million |
|
Lipum AB
ST:LIPUM
|
Sweden | Skr11.63 Million |
Liability Composition Analysis (2023–2025)
This chart breaks down Bayview Acquisition Corp Class A Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Bayview Acquisition Corp Class A Ordinar.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bayview Acquisition Corp Class A Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bayview Acquisition Corp Class A Ordinary Shares (2023–2025)
The table below shows the annual total liabilities of Bayview Acquisition Corp Class A Ordinary Shares from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $5.57 Million | +64.66% |
| 2024-12-31 | $3.38 Million | +40.07% |
| 2023-12-31 | $2.41 Million | -- |
About Bayview Acquisition Corp Class A Ordinary Shares
Bayview Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Bayview Acquisition Corp was incorporated in 2023 and is headquartered in New York, New York.